Blood test may speed up deadly fungal infection diagnosis
NCT ID NCT07272915
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at a blood test called Beta-D-glucan (BDG) to see how well it detects invasive fungal infections in people with weak immune systems. Researchers tested 280 patients and checked if two positive results within 15 days confirmed an infection. The goal is to help doctors diagnose faster and start treatment sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Beta-D-glucan (BDG) blood test
- What this could lead to
- If successful, this could improve how quickly and accurately doctors diagnose serious fungal infections, potentially saving lives.
- What could go wrong
- This is a completed study analyzing past data, not a new treatment. The test may still produce false positives or negatives, and results may not apply to all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPERGILLOSIS INVASIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Nancy
Vandœuvre-lès-Nancy, 54500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a quick PCR test speed up lifesaving fungal infection diagnosis?
- Blood biomarkers may let ICU patients stop antifungals earlier
- Immune booster shows promise in fighting dangerous fungal infection
- Could 7 days of antifungals be enough for kids with blood infections?
- Could a lower dose of antibiotics be safer and just as effective for this lung infection?
- Candida resistance study pulled before it began